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Abstract
Homocystinuria is a metabolic disorder associated with an increased incidence of vascular disease. Here, we analyzed the
effects of homocysteine on endothelial cell activation that is a prerequisite for the recruitment of leukocytes to sites of
evolving atherosclerotic plaques. Exposure of human umbilical vein endothelial cells to homocysteine alone did not modulate
expression of the adhesion molecules E-selectin, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1, and
the chemokines monocyte chemotactic protein-1 and interleukin-8. In contrast, tumor necrosis factor (TNF)-induced
upregulation of these molecules was almost completely inhibited by homocysteine, but not by related thiol amino acids.
Using electrophoretic mobility shift and reporter gene assays, the inhibitory effect of homocysteine could be attributed to
inhibition of DNA binding and transcriptional activity of NF-UB. TNF-induced phosphorylation and degradation of IUB-K,
however, were not affected. Neither was NF-UB-independent activation of endothelial cells by interferon-Q influenced by
homocysteine. In summary, our data indicate that homocysteine alters the response to injury of endothelial cells which may
have fundamental impacts on mechanisms of leukocyte recruitment to sites of inflammation. Our findings might refer to a
novel pathway by which homocysteine is involved in vascular disorders associated with homocystinuria. ß 2001 Elsevier
Science B.V. All rights reserved.
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1. Introduction
Homocystinuria is an autosomal recessive disorder
that arises from congenital de¢ciency of a number of
distinct enzyme activities [1]. This inborn metabolic
defect is associated with an increased incidence of
vascular disease, and even moderate hyperhomocys-
teinemia represents a major independent risk factor
in the pathogenesis of atherosclerosis in the general
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population [1]. Using an animal model, it has been
shown that diet-induced hyperhomocysteinemia al-
ters vascular functions [2]. The mechanisms by which
elevated serum levels of homocysteine lead to vascu-
lar disease, however, are rather unknown [1,3,4]. Hy-
perhomocysteinemia has been assumed to result in
endothelial dysfunction, which, according to the re-
sponse-to-injury hypothesis, is one of the primary
steps in the pathogenesis of atherosclerosis [5]. Sub-
sequently, accumulation of macrophages and T lym-
phocytes is observed which results in an excessive
in£ammatory ¢broproliferative reaction, platelet ac-
cumulation and thrombus formation [1,5,6]. Regard-
ing the endothelium, however, previous studies on
hyperhomocysteinemia have mainly focused on pro-
coagulant e¡ects of this amino acid, whereas its in-
£uences on in£ammatory activities have been more
or less neglected [1,3].
Activation of endothelial cells is a necessary pre-
requisite for the recruitment of leukocytes to sites of
evolving in£ammation: adhesion molecules and che-
motactically active cytokines are expressed which de-
termine the qualitative and quantitative composition
of the leukocyte in¢ltrate [1,6,7]. Extracellular stimuli
such as tumor necrosis factor (TNF) and interleukin
(IL)-1 activate intracellular signal transduction cas-
cades which converge at a common mechanism of
gene regulation and result in the activation of tran-
scription factor nuclear factor-UB (NF-UB) [8,9]. In
endothelial cells, proin£ammatory cytokines rapidly
induce NF-UB DNA binding and cause upregulation
of NF-UB-dependent genes, such as the adhesion
molecules E-selectin, intercellular adhesion mole-
cule-1 (ICAM-1) and vascular cell adhesion mole-
cule-1 (VCAM-1), or chemokines, such as macro-
phage chemoattractant protein-1 (MCP-1) or IL-8
[7]. In resting cells, the inhibitory subunit IUB-K is
predominantly bound to the p50/p65 heterodimer of
NF-UB in the cytoplasm. Treatment of endothelial
cells with e.g. TNF results in the speci¢c phosphor-
ylation of two serine residues of IUB-K followed by
its ubiquitination and proteolytic degradation. Sub-
sequently, active NF-UB is released and translocated
to the nucleus where it activates gene transcription
[8,9].
In the present study, we demonstrate that homo-
cysteine, in contrast to related thiol containing amino
acids, selectively inhibited TNF-induced expression
of endothelial adhesion molecules and chemokines.
Homocysteine prevented NF-UB DNA binding and
subsequent gene transcription by an alternative path-
way which did not involve IUB-K phosphorylation
and degradation. Interferon (IFN)-Q-induced activa-
tion of vascular endothelium, however, was not in-
£uenced by homocysteine. Thus, homocysteine
causes an imbalance between distinct intracellular
signaling pathways resulting in an altered endothelial
pattern of response to injury.
2. Material and methods
2.1. Reagents
DL-Homocysteine, L-homocystine, L-cysteine and
L-methionine were obtained from Sigma (Deisenho-
fen, Germany). The L-stereoisomer of homocysteine,
which is not commercially available, was prepared
from L-homocysteine thiolactone (Sigma) [10]. Due
to its poor solubility homocystine was solubilized
at pH 8.5 and subsequently neutralized to pH 7.2
with HCl. Human recombinant TNF and IFN-Q
were purchased from Roche Molecular Biochemicals
(Mannheim, Germany) and Peprotech (London,
UK). Monoclonal antibodies (mAbs) against E-selec-
tin and VCAM-1 were purchased from RpD Sys-
tems (Wiesbaden, Germany), against ICAM-1 from
Immunotech (Dianova, Hamburg, Germany), and
against MCP-1 and IL-8 from BD (Heidelberg, Ger-
many). Fluorescein isothiocyanate- or horseradish
peroxidase-conjugated goat anti-mouse F(abP)2
secondary antibodies were obtained from Immuno-
tech.
2.2. Cell culture
Human umbilical vein endothelial cells (HUVEC),
either isolated from umbilical cord vessels at our in-
stitution or purchased from Clonetics (via Cell Sys-
tems, St. Katharinen, Germany), were cultured as
previously described [11,12].
2.3. Detection of adhesion molecule expression
HUVEC cultured in 96-well £at-bottomed micro-
titer plates or T25 culture £asks were preexposed to
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DL-homocysteine, L-homocysteine thiolactone, L-ho-
mocystine, L-cysteine, or L-methionine at concentra-
tions between 0.5 and 5 mmol/l for 30 min and sub-
sequently stimulated with 5 ng/ml TNF or medium
as indicated. Thereafter, endothelial adhesion mole-
cule expression was determined by a cellular ELISA
technique or by £ow cytometry as described previ-
ously [12]. In order to permit determination of cell
viability and exclusion of nonviable cells, propidium
iodide (Sigma) was added prior to FACS analysis.
Cell viability was found to be greater than 95% in
all experiments.
2.4. Detection of chemokine expression
Expression of the chemokines MCP-1 and IL-8
was determined by an intracellular staining proce-
dure. HUVEC were stimulated as indicated in the
presence of 2 Wmol/l monensin (Sigma), washed,
¢xed, permeabilized and chemokine expression quan-
ti¢ed by £ow cytometry after staining with phycoer-
ythrin-labeled mouse mAbs against MCP-1 or IL-8
as described earlier [11,12]. Chemokine secretion by
endothelial cells exposed to TNF in the presence or
absence of di¡erent amino acids was studied by
sandwich ELISA systems as previously reported
[11].
2.5. Determination of intracellular homocysteine
concentrations
HUVEC (2U106) were harvested, washed twice
with phosphate-bu¡ered saline and homogenized by
soni¢cation. Following chemical reduction using tri-
n-butylphosphine and derivatization with SBD-F
(ammonium-7-£uorobenzo-L-oxa-1,3-diazo-4-sulfo-
nate) measurement of total intracellular homocys-
teine was performed as described earlier [13]. Total
homocysteine concentrations as low as 0.1 nmol/mg
protein could be detected.
2.6. Transient transfection procedures and luciferase
assay
Cells were transfected with a luciferase reporter
gene construct controlled by either six UB sites
[14,15] or the proximal promoter and distal enhancer
region of the human MCP-1 gene [16]. After trans-
fection HUVEC were cultured for 30 h and ¢nally
stimulated with TNF in the absence or presence of
homocysteine. Luciferase activity was determined as
described [17].
2.7. Electrophoretic mobility shift assays and Western
blot
NF-UB DNA binding activity was determined by
electrophoretic mobility shift assays. IUB-K degrada-
tion and, using phosphospeci¢c antibodies, IUB-K
phosphorylation were studied by Western blot anal-
ysis as described earlier [18,19].
2.8. Statistics
The U-test according to Mann and Whitney (for
values without normal distribution) was performed
to determine signi¢cance of di¡erences (Ps 0.05).
3. Results
3.1. Homocysteine blocks TNF-induced expression of
endothelial adhesion molecules
Homocysteine has been supposed to promote the
production of reactive oxygen intermediates [3,20]
which might be involved in the regulation of endo-
thelial activation [21,22]. Therefore, we ¢rst investi-
gated the e¡ect of homocysteine on the expression of
endothelial adhesion molecules. HUVEC were ex-
posed to 5 mmol/l homocysteine and analyzed for
adhesion molecule expression by £ow cytometry.
As shown in Fig. 1, treatment with solely homocys-
teine did not a¡ect the expression of ICAM-1,
VCAM-1 or E-selectin. In contrast, in£ammatory
activation of endothelium by TNF could e⁄ciently
be blocked by pretreatment with homocysteine (Fig.
1).
The inhibitory e¡ects of homocysteine were dose-
dependent with a half-maximal inhibition of TNF-
induced E-selectin expression at 2 mmol/l homocys-
teine (Fig. 2A). An almost identical dose^response
relationship was obtained for L-homocysteine thio-
lactone (Fig. 2B), indicating that the physiological
L-isomer of homocysteine was capable of inhibiting
E-selectin expression. In contrast, related thiol con-
BBAMCR 14783 9-8-01
J. Roth et al. / Biochimica et Biophysica Acta 1540 (2001) 154^165156
taining amino acids such as L-homocystine, L-cys-
teine and L-methionine showed no signi¢cant inhibi-
tion at all (Fig. 2C^E). Essentially similar results
were obtained when the inducible expression of
ICAM-1 and VCAM-1 was examined (data not
shown).
In parallel, we determined the intracellular concen-
trations of homocysteine in endothelial cells after
incubation with homocysteine (0.25^5 mmol/l), ho-
mocystine (5 mmol/l), cysteine (5 mmol/l), or methio-
nine (5 mmol/l). Extracellular homocysteine in-
duced a dose-dependent increase in intracellular
homocysteine concentrations (basal intracellular con-
centration 0^1 nmol/mg protein) which became
signi¢cant at an extracellular concentration of
2 mmol/l (intracellular concentration 4^7.5 nmol/mg
protein) and maximal at 5 mmol/l (intracellular con-
centration 12^28 nmol/mg protein). Neither homo-
cystine, cysteine nor methionine led to an increase
in intracellular homocysteine even at concentrations
of 5 mmol/l (Fig. 2F). Thus, the increase in the intra-
cellular homocysteine concentration in endothelial
cells showed a close correlation with its inhibitory
e¡ect on TNF-induced expression of adhesion mole-
cules.
3.2. Inhibition of TNF-induced expression of
C-C chemokine MCP-1 and C-X-C chemokine
IL-8 by homocysteine
We next analyzed the e¡ect of homocysteine on
expression of the chemokines MCP-1 and IL-8,
which play important roles for leukocyte recruit-
ment. Homocysteine dose-dependently blocked
TNF-induced release of MCP-1 (Fig. 3A) and IL-8
(Fig. 3B) into the culture supernatant of HUVEC.
Intracellular £ow cytometry revealed an inhibition
of TNF-induced MCP-1 and IL-8 expression by ho-
mocysteine, indicating that blockade occurred at the
level of de novo synthesis rather than by inhibition
of release (Fig. 3C). Essentially similar results were
obtained for MCP-1 and IL-8 expression at the
mRNA level using Northern blot analysis (data not
shown).
3.3. Homocysteine inhibits TNF-induced NF-UB
activation
The expression of many proin£ammatory endothe-
lial gene products, in particular of adhesion mole-
cules and chemokines, is essentially controlled by
Fig. 1. Homocysteine blocks TNF-induced surface expression of ICAM-1, VCAM-1 and E-selectin in HUVEC. Cells were treated
with 5 ng/ml TNF or medium alone in the absence or presence of 5 mmol/l homocysteine which was added 30 min prior to stimula-
tion. Flow cytometry pro¢les of cells stained with control IgG (white) and mAb against adhesion molecules (shaded) are depicted.
Data of one of three independent experiments with similar results are presented.
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the transcriptional activator NF-UB. We therefore
investigated whether homocysteine interfered with
NF-UB activation. Employing electrophoretic mobil-
ity shift assays TNF was found to strongly induce
NF-UB DNA binding in HUVEC (Fig. 4A). Compe-
tition analysis with wild-type and mutated oligonu-
cleotides con¢rmed that the TNF-induced DNA^
protein complex was speci¢c for NF-UB (data not
shown; see Goebeler et al. [19]). Induction of NF-
UB binding activity was signi¢cantly inhibited by DL-
homocysteine and L-homocysteine thiolactone,
whereas no e¡ects were seen with L-cysteine and
L-homocystine (Fig. 4A).
To study whether homocysteine interfered with
NF-UB-mediated transactivation, HUVEC were
transiently transfected with a NF-UB-controlled lucif-
erase construct. As shown in Fig. 4B, stimulation of
HUVEC with TNF strongly upregulated NF-UB-
mediated expression of the luciferase construct,
whereas concomitant exposure to homocysteine com-
Fig. 2. Dose response of homocysteine and related amino acids on TNF-induced E-selectin expression. HUVEC were cultured in the
presence of DL-homocysteine (A), L-homocysteine thiolactone (B), L-homocystine (C), L-cysteine (D) or L-methionine (E) at the indi-
cated concentrations and exposed to medium or 5 ng/ml TNF for 4 h. E-Selectin expression was determined by cell ELISA. E-Selectin
expression (OD) is presented as mean þ S.E.M. of quadruplicates of one of three representative experiments. In addition, intracellular
homocysteine concentrations were determined after 4 h incubation with homocysteine (0.25^5 mmol/l), homocystine (5 mmol/l), cys-
teine (5 mmol/l), or methionine (5 mmol/l) (F). One of three representative experiments is shown.
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Fig. 3. Inhibition of TNF-induced expression of chemokines MCP-1 and IL-8 by homocysteine. HUVEC were left untreated or pre-
treated with 5 mmol/l homocysteine for 30 min and subsequently stimulated with 5 ng/ml TNF for 16 h in the absence or presence of
homocysteine. Supernatants were analyzed for secretion of MCP-1 (A) and IL-8 (B) employing a sandwich ELISA technique. Data
(ng/ml) are expressed as mean þ S.E.M. of triplicate wells. (C) HUVEC were stimulated as described but additionally cultured in the
presence of 2 Wmol/l monensin in order to prevent protein secretion. Synthesis of MCP-1 and IL-8 was determined by an intracellular
staining procedure and subsequent £ow cytometry as described in Section 2. Flow cytometry pro¢les of HUVEC stained with control
IgG (white) and a mAb against MCP-1 or IL-8 (shaded) are depicted. Data of one of three independent experiments with similar re-
sults are presented.
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pletely suppressed luciferase induction by TNF. We
then analyzed the e¡ect of homocysteine on the tran-
scriptional regulation of the MCP-1 promoter.
Again, exposure to homocysteine alone did not a¡ect
levels of luciferase transcription, whereas it signi¢-
cantly inhibited TNF-induced transcription of the
MCP-1 promoter/enhancer luciferase construct (Fig.
4C). Our data thus suggest that the suppressing ef-
fects of homocysteine on TNF-induced gene expres-
sion involved inhibition of NF-UB activation.
3.4. Homocysteine does not a¡ect IUB-K
phosphorylation and degradation
In the next experiments, we analyzed whether ho-
mocysteine a¡ected phosphorylation and degrada-
tion of IUB-K which is a prerequisite for most path-
ways of NF-UB activation. Treatment of HUVEC
with TNF led to a rapid degradation of IUB-K within
15 min, followed by its resynthesis after 45 min (Fig.
5). Pretreatment of cells with homocysteine had no
Fig. 4. Inhibition of NF-UB DNA binding and gene transactivation by homocysteine. (A) HUVEC were treated with medium as con-
trol or 5 ng/ml TNF for 1 h in the presence of 5 mmol/l DL-homocysteine, L-homocysteine thiolactone, L-homocystine, or L-cysteine
which had been added to the culture medium 30 min prior to TNF stimulation. Cell extracts were subsequently analyzed for DNA
binding activity by electrophoretic mobility shift assays using a 32P-labeled oligonucleotide encompassing the mouse U light chain con-
sensus sequence. Autoradiographs of one of three representative experiments are shown. (B) HUVEC transfected with a luciferase re-
porter gene construct controlled by six UB binding sites were stimulated as indicated. Subsequently, cells were lysed and NF-UB-medi-
ated transactivation determined by luciferase assay as described in Section 2. Results (relative light units) of one representative
experiment (n = 3) are presented as mean þ S.E.M. of quadruplicates. (C) HUVEC transfected with a human MCP-1 promoter/en-
hancer luciferase construct were exposed to TNF and homocysteine as described in B and studied for induced reporter gene expres-
sion.
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signi¢cant e¡ect on the loss and reappearance of
IUB-K. Similarly, homocysteine did not exert an ob-
vious e¡ect on TNF-induced phosphorylation of
IUB-K (Fig. 5). Identical results were obtained when
phosphorylation was studied in the presence of pro-
teasome inhibitor MG115 which blocks degradation
of phosphorylated IUB-K (data not shown). Thus, in
contrast to other thiol agents such as pyrrolidine
dithiocarbamate and N-acetylcysteine that have
been shown to inhibit IUB-K phosphorylation and
degradation [23], homocysteine appeared to block
NF-UB activation via an alternative pathway.
3.5. Homocysteine does not interfere with IFN-Q-
induced endothelial activation
To address the question whether homocysteine ex-
clusively a¡ects NF-UB-dependent endothelial signal
pathways or is a more general inhibitor of endothe-
lial activation, we studied its e¡ects on IFN-Q-in-
duced expression of ICAM-1. In contrast to the in-
hibitory e¡ect on TNF-mediated ICAM-1
upregulation (see Fig. 1), homocysteine did not alter
IFN-Q-induced ICAM-1 expression (Fig. 6), indicat-
ing that its action was rather speci¢c. Similar results
were obtained for IFN-Q-induced HLA-DR expres-
sion in endothelial cells (data not shown).
4. Discussion
The present data provide evidence that homocys-
teine extensively interferes with in£ammatory func-
tions of endothelial cells at the level of gene expres-
sion. In£ammatory induction of the endothelial
adhesion molecules E-selectin, ICAM-1 and
VCAM-1 as well as of the chemokines MCP-1 and
IL-8 in response to TNF was signi¢cantly inhibited
by concomitant exposure to homocysteine in a con-
centration-dependent manner. Inhibition of endothe-
lial activation was not only achieved by treatment
with DL-homocysteine but also with L-homocysteine
thiolactone, indicating that the physiologically rele-
Fig. 6. IFN-Q-induced ICAM-1 expression is not inhibited by homocysteine. HUVEC were treated with either medium as control, 10
ng/ml IFN-Q, 5 mmol/l homocysteine, or with both IFN-Q and homocysteine for 48 h. ICAM-1 surface expression was subsequently
analyzed by £ow cytometry. FACS pro¢les of HUVEC stained with control IgG (white) and a mAb against ICAM-1 (shaded) are
shown. Data of one of three independent experiments with similar results are presented.
Fig. 5. Homocysteine does not inhibit TNF-induced phosphory-
lation and degradation of IUB-K. HUVEC were exposed to
5 ng/ml TNF for 0, 5, 15 and 45 min in the absence or pres-
ence of 5 mmol/l homocysteine which had been added 30 min
prior to TNF stimulation. Total cellular protein was separated
by SDS^PAGE and examined for IUB-K phosphorylation at
serine 32 or IUB-K degradation by Western blot analysis using
phosphorylation site-speci¢c antibodies.
BBAMCR 14783 9-8-01
J. Roth et al. / Biochimica et Biophysica Acta 1540 (2001) 154^165 161
vant L-isomer of homocysteine exerts such e¡ects.
Suppression of TNF-mediated activation by homo-
cysteine was highly speci¢c, since neither other thiol
containing amino acids nor its oxidized form, homo-
cystine, revealed any inhibitory e¡ects. In this con-
text it has to be considered that homocystine is
signi¢cantly less soluble compared to homocys-
teine.
Patients with homocystinuria have been reported
to contain serum levels of up to 0.5 mmol/l of total
homocysteine, whereas for the in vitro e¡ects 2^5-
fold higher concentrations are required [3,24]. How-
ever, our data clearly indicate that increases in intra-
cellular homocysteine concentrations were responsi-
ble for the inhibitory e¡ects on endothelial
activation. HUVEC used in our study were from
healthy donors and did not su¡er from homocysti-
nuria, thus presenting normal activities of cysta-
thione-L-synthase, the enzyme a¡ected in classic ho-
mocystinuria. Extracellular levels of homocysteine in
the range of 1^5 mmol/l are therefore necessary to
ensure a su⁄cient elevation of intracellular homocys-
teine. In contrast to our cellular model, elevated
extracellular homocysteine levels in homocystinuria
are a secondary phenomenon and primarily caused
by its intracellular accumulation due to a disturbed
homocysteine metabolism. Endothelial cells of pa-
tients with homocystinuria are not available but their
intracellular levels are presumably in the range of the
concentrations measured in patients’ sera and thus
even higher than the intracellular homocysteine con-
centrations found to be e¡ective in HUVEC. The
question whether long-term exposure of the vascular
endothelium with only slightly elevated homocysteine
concentrations has a pathological e¡ect over years,
which would be of relevance for homocysteine as an
atherogenic risk factor, cannot be answered by this
short-term in vitro model.
Oxidative stress has been implicated in the regula-
tion of gene expression; especially endothelial cells
were found to be highly sensitive for changes of their
redox state, which result in the activation of distinct
nuclear transcription factors and gene transcription
[21,25,26]. Homocysteine, although reported to act
through induction of oxidative stress [3,20], unex-
pectedly failed to activate endothelial cells. Neither
induction of transcription factor NF-UB DNA bind-
ing activity nor upregulation of endothelial adhesion
molecules and chemokines which both re£ect activa-
tion of endothelium could be observed after exposure
to homocysteine. This indicates that, in contrast to
smooth muscle cells [3], formation of reactive oxygen
species by homocysteine does not appear to be rele-
vant, at least in our model of endothelial activation.
In contrast, homocysteine blocked agonist-induced
activation of endothelium, suggesting that it might
exhibit antioxidant rather than prooxidant proper-
ties. Similar to antioxidants such as pyrrolidine di-
thiocarbamate, cysteine and N-acetylcysteine which
are known to inhibit NF-UB DNA binding activity
[21,27], homocysteine contains a thiol group that
could act as a potential radical scavenger. However,
as also reported in a recent study [28], in endothelial
cells the inhibitory e¡ect was rather speci¢c for ho-
mocysteine and not detectable with cysteine or other
thiols. Thus, we consider it rather unlikely that the
inhibitory action of homocysteine is mediated by an
unspeci¢c thiol e¡ect. N-Acetylcysteine and pyrroli-
dine dithiocarbamate have been shown to inhibit
phosphorylation and subsequent degradation of
IUB-K [23]. Interestingly, homocysteine had no sub-
stantial e¡ect on TNF-induced phosphorylation and
degradation of IUB-K. These data are comparable to
those described for the e¡ects of another antioxidant
substance, DMSO, on TNF-induced, NF-UB-depen-
dent expression of IL-8 [29]. Recently, it was shown
that homocysteine can directly modify proteins and
lead to protein damage and dysfunction through a
mechanism called homocysteinylation [30]. Whether
NF-UB proteins and their DNA binding activity are
modulated by a similar or an alternative underlying
process is currently under investigation.
Our observations appear to be remarkable with
respect to the pathogenesis of atherosclerosis in ho-
mocystinuria: initial injury of the endothelial cell lin-
ing is supposed to be associated with endothelial
dysfunction that ultimately results in the formation
of ¢brous atherosclerotic plaques. In injured blood
vessels as well as in advanced atherosclerotic lesions
apoptosis has been observed to occur [31^33]. A ma-
jor factor modulating in£ammatory responses in the
endothelium exposed to stimulating agents is TNF.
Recent studies reported that the signaling cascades
triggered by TNF receptor-1 can be dissected into
distinct pathways. One signaling pathway involves
the recruitment of the death domain containing
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adaptor protein FADD which ¢nally results in cas-
pase activation and apoptosis. Another separate re-
sponse leads to NF-UB activation and expression of
antiapoptotic target genes [34^37]. As homocysteine
inhibits TNF-mediated NF-UB activation, this may
be associated with a suppression of antiapoptotic
pathways. In fact, a recent report showed that ho-
mocysteine is capable to induce apoptosis in endo-
thelial cells [38]. It is thus conceivable that homocys-
teine-mediated inhibition of mechanisms that prevent
cell death might contribute to endothelial damage
which, according to the ‘response-to-injury’ hypoth-
esis [5], is an early step in atherogenesis. Accordingly,
it has been shown that apoptotic endothelial cells
become procoagulant which is known to be a major
risk factor for atherosclerosis [39]. This procoagulant
phenotype may also be responsible for the increased
leukocyte adherence to endothelial cells induced by
homocysteine in an animal model of in£ammation
[22].
In addition to e¡ects causing cell damage, homo-
cysteine may interfere with immunoregulatory mech-
anisms that are necessary for a normal vascular func-
tion. At ¢rst view, our observation that
homocysteine inhibits endothelial activation is sur-
prising, as expression of NF-UB-dependent genes
such as MCP-1 and VCAM-1 has been shown to
be important for the atherogenic process. However,
endothelial NF-UB activation usually re£ects an
acute response to injury under many in£ammatory
conditions which do not necessarily result in chronic
in£ammation of the vessel wall. It has rather been
shown that NF-UB-mediated events are required for
an appropriate in£ammatory response that allows
regeneration of endothelium ad integrum. In an ar-
terial injury model, NF-UB activation with subse-
quent adhesion molecule expression and monocyte
recruitment could be observed after partial mechan-
ical denuding of aortic endothelium [40]. Neverthe-
less, complete regeneration occurred and endothelial
activation parameters were downregulated. Such
events may re£ect an autoregulatory repair mecha-
nism which may be important for maintenance of
vascular homeostasis [40].
Atherosclerosis represents a prolonged disturbance
of vascular homeostasis which involves in¢ltration by
a considerable number of activated lymphocytes, ex-
pression of IFN-Q and, subsequently, IFN-Q-induc-
ible gene products such as ICAM-1, HLA-DR, neo-
pterin and MCP-1 [41,42]. Our data demonstrate
that homocysteine inhibits TNF- but not IFN-Q-in-
duced gene transcription in endothelium; it thus
causes an imbalance in intracellular signaling rather
than a complete suppression of endothelial cell func-
tion. In contrast to TNF, IFN-Q does not lead to
endothelial expression of E-selectin and IL-8, both
of which are required for the recruitment of neutro-
phils. MCP-1 expression, however, which has been
associated with the recruitment of mononuclear cells
in atherosclerotic lesions [43], can still be induced
under conditions where TNF-mediated signaling via
NF-UB is inhibited. Thus, the e¡ects of homocysteine
on endothelial activation may refer to a pathomech-
anism preferring the recruitment of mononuclear
cells to sites of endothelial injury and thereby may
result in the prolonged in£ammatory response typical
for atherosclerotic lesions.
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